投資のアイデア
すべての銘柄を見る
市場
ホーム
ポートフォリオ
ウォッチリスト
コミュニティ
発見
スクリーナー
ホーム
ポートフォリオ
ウォッチリスト
コミュニティ
発見
スクリーナー
Biotech Breakthroughs - Investing Ideas - Simply Wall St
投資のアイデア
›
Biotech Breakthroughs
スクリーナーの編集
新規株式アラートを受け取る
Biotech Breakthroughs
結果
86
1 新しい
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
🌎 グローバル
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Pharmaceuticals & Biotech
All Industries
Automobiles
Banks
Capital Goods
Commercial Services
Consumer Durables
Consumer Services
Diversified Financials
Energy
Consumer Retailing
Food, Beverage & Tobacco
Healthcare
Household
Insurance
Materials
Media
Pharmaceuticals & Biotech
Real Estate
Retail
Semiconductors
Software
Tech
Telecom
Transportation
Utilities
86 各社
1 新規参入企業直近7社
会社概要
最終価格
7Dリターン
1Yリターン
時価総額
アナリストの目標
評価
成長
配当利回り
A290650
L&C BIOLTD
₩46,500.00
-5.5%
-24.0%
₩1.3t
₩95,000.00
PS
10.8
E
163.0%
0.1%
2480
Beijing Luzhu Biotechnology
HK$13.56
-0.3%
-44.7%
HK$2.7b
HK$31.00
PB
3.9
E
84.3%
n/a
MDGL
Madrigal Pharmaceuticals
US$534.40
0.2%
21.2%
US$12.2b
US$678.06
PS
9.6
E
63.7%
n/a
A042520
HansBiomed
₩18,160.00
-9.7%
13.5%
₩259.0b
n/a
PS
2.1
E
69.6%
0%
INSM
Insmed
US$123.98
-2.6%
-15.0%
US$26.8b
US$199.55
PS
23.8
E
67.1%
n/a
ARDX
Ardelyx
US$3.39
-6.4%
-47.2%
US$844.7m
US$12.90
PS
1.9
E
61.5%
n/a
9926
Akeso
HK$90.75
-3.0%
-30.7%
HK$83.6b
HK$156.18
PS
20.7
E
51.3%
n/a
PRAX
Praxis Precision Medicines
US$310.47
-8.3%
586.4%
US$8.6b
US$638.68
PB
6.5
E
71.7%
n/a
RYTM
Rhythm Pharmaceuticals
US$99.02
-3.1%
0.5%
US$6.7b
US$138.59
PS
28.4
E
69.6%
n/a
MRKR
Marker Therapeutics
US$1.18
-1.7%
22.9%
US$19.0m
US$7.87
PS
5.5
E
72.5%
n/a
9887
Nanjing Leads Biolabs
HK$55.75
-10.1%
-16.7%
HK$10.9b
HK$105.23
PS
43.6
E
48.8%
n/a
ZYME
Zymeworks
US$27.48
4.0%
66.6%
US$1.9b
US$41.23
PS
52.5
E
36.1%
n/a
IONS
Ionis Pharmaceuticals
US$46.75
-16.0%
-24.3%
US$7.5b
US$83.82
PS
8.9
E
68.1%
n/a
2171
CARsgen Therapeutics Holdings
HK$12.30
-1.4%
-40.7%
HK$6.9b
HK$18.33
PS
43.3
E
106.9%
n/a
ABEO
Abeona Therapeutics
US$5.59
2.0%
-0.9%
US$307.1m
US$18.63
PS
12.5
E
70.8%
n/a
ALDX
Aldeyra Therapeutics
US$1.38
-5.5%
-72.5%
US$82.6m
US$6.60
PB
2.2
E
55.2%
n/a
LCTX
Lineage Cell Therapeutics
US$1.03
1.0%
-33.5%
US$270.6m
US$5.50
PS
19.9
E
74.5%
n/a
ACE
Ascelia Pharma
SEK 0.57
-10.7%
-85.0%
SEK 80.4m
SEK 2.39
PB
0.9
E
117.0%
n/a
DBV
DBV Technologies
€2.22
-1.9%
36.7%
€620.2m
€3.64
PS
149.9
E
68.9%
n/a
CLRB
Cellectar Biosciences
US$2.40
1.3%
-56.3%
US$22.2m
US$11.50
PB
0.8
E
56.0%
n/a
TNYA
Tenaya Therapeutics
US$0.67
3.6%
-49.1%
US$147.5m
US$3.20
PS
112.9
E
67.8%
n/a
INMB
INmune Bio
US$2.18
-5.6%
10.7%
US$56.9m
US$7.00
PB
3.0
E
43.4%
n/a
CAPR
Capricor Therapeutics
US$9.42
13.5%
47.2%
US$497.7m
US$27.00
PB
2.2
E
67.4%
n/a
RVMD
Revolution Medicines
US$196.94
-3.2%
335.5%
US$42.0b
US$251.21
PB
16.2
E
63.5%
n/a
Page 1 of 3